Following events at the ADA Scientific Sessions in June, a number of concerns raised regarding the ADA's professional section remain unresolved. As a result, a boycott of ADA activities has been initiated by leading figures in diabetes research. The text below includes relevant hyperlinks with further information. Those who wish to review the petition and consider whether to sign it may do so at the links provided. This information is being shared for member awareness.

Stanford Medicine endocrinologist Sun H. Kim, MD, MS, and bariatric surgeon Dan Azagury, MD, FACS, break down how GLP-1 medications work, who may benefit, and why they're not a one-size-fits-all solution. [Watch the video →]. Read full Article here.

SDRC member Anna Gloyn and others lead efforts mapping diabetes risk to pancreatic islet cell heterogeneity and genes that could drive variation in blood sugar regulation.